Author

Amy M. Bertino

Mass General Brigham

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Angelique Gilbert· 1 shared Claudia C. PastranaiD· 1 shared Kimmo PorkkaiD· 1 shared Matthew J. WalteriD· 1 shared Samuli EldforsiD· 1 shared Sridhar Nonavinkere SrivatsaniD· 1 shared Sumit RaiiD· 1 shared Tareq HossaniD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Angelique Gilbert

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Sensitivity to ATR-CHK1 pathway inhibition in AML/MDS is enhanced by SRSF2 mutations and reduced by RUNX1 loss

Samuli Eldfors, Sumit Rai, Vineet Sharma, Tareq Hossan, Claudia C. Pastrana, Amy M. Bertino, Angelique Gilbert, Sridhar Nonavinkere Srivatsan, Kimmo Porkka, Matthew J. Walter, Timothy Aaron Graubert

This study identifies SRSF2 and U2AF1 mutations as biomarkers of sensitivity to ATR-CHK1 pathway inhibitors and RUNX1 mutations as a mechanism of resistance in MDS/AML.

Leukemia · Oct 6, 2026Peer-reviewedCancer Biology